Fortress Biotech, Inc. (FBIO) vs PDS Biotechnology Corporation (PDSB)

A side-by-side comparison of Fortress Biotech, Inc. and PDS Biotechnology Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — FBIO vs PDSB

growth of $100 · dividends reinvested · last 10y
FBIO -95.1% (-26.1%/yr)PDSB -99.4% (-40.3%/yr)FBIO compounded faster over this window
Log scale — wide-divergence pair
001101001kStart $10020182020202220242026$5$1
FBIO PDSB

FBIO vs PDSB: by the numbers

  • •FBIO is the larger company ($68M vs $64M market cap).
  • •FBIO is profitable (163.32% net margin) while PDSB runs a net loss (0.00%).

Metrics side by side

Valuation

MetricFBIOPDSB
P/E ratio0.76N/A
P/S ratio0.99N/A
P/B ratio0.41N/A
FCF yield186.15%N/A

Profitability

MetricFBIOPDSB
Gross margin62.53%0.00%
Operating margin-111.00%0.00%
Net margin163.32%0.00%
ROE68.12%N/A
ROIC-10.85%-3699.99%

Growth (annualized)

MetricFBIOPDSB
Revenue CAGR (5Y)5.39%N/A
Total return CAGR (5Y)-46.06%-39.13%

Frequently asked

Is FBIO or PDSB more profitable?
FBIO runs the higher net margin — FBIO at 163.32% versus PDSB at 0.00%.
How have FBIO and PDSB total returns compared?
Over the past 10 years, FBIO delivered -26.29% and PDSB delivered -40.75% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.